| Literature DB >> 35049183 |
Wen Jia1, Chuan Wang, Ying Yin.
Abstract
BACKGROUND: Acupuncture is widely used for oligospermia and asthenozoospermia in China, but its effect is unclear. We aimed to determine the effectiveness and safety of acupuncture in treating oligospermia and asthenozoospermia.Entities:
Mesh:
Year: 2021 PMID: 35049183 PMCID: PMC9191280 DOI: 10.1097/MD.0000000000027816
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Search strategy used in PubMed.
| Number | Search items |
| 1 | Randomized controlled trial.pt |
| 2 | Randomized.ti,ab |
| 3 | Randomly.ti,ab |
| 4 | Groups.ti,ab |
| 5 | Trial.ti,ab |
| 6 | Or 1 to 5 |
| 7 | Acupuncture.ti,ab |
| 8 | Electroacupuncture.ti,ab |
| 9 | Scalp acupuncture.ti,ab |
| 10 | Three edged needle.ti,ab |
| 11 | Fire needle.ti,ab |
| 12 | Auricular acupuncture.ti,ab |
| 13 | Dry needling.ti,ab |
| 14 | Warm acupuncture.ti,ab |
| 15 | Pyonex.ti,ab |
| 16 | Manual acupuncture.ti,ab |
| 17 | Or 7 to 16 |
| 18 | Oligospermia.ti,ab |
| 19 | Low sperm count.ti,ab |
| 20 | Hypospermatogenesis.ti,ab |
| 21 | Hypospermatogeneses.ti,ab |
| 22 | Disc herniation-induced sciatica.ti,ab |
| 23 | Low sperm counts.ti,ab |
| 24 | Sperm count, low.ti,ab |
| 25 | Sperm counts, low.ti,ab |
| 26 | Oligoasthenoteratozoospermia.ti,ab |
| 27 | Oligoasthenoteratozoospermias.ti,ab |
| 28 | Oligozoospermia.ti,ab |
| 29 | Or 18 to 28 |
| 30 | Asthenospermia.ti,ab |
| 31 | Astheno teratozoospermia.ti,ab |
| 32 | Astheno teratozoospermias.ti,ab |
| 33 | Teratozoospermia, astheno.ti,ab |
| 34 | Teratozoospermias, astheno.ti,ab |
| 35 | Asthenoteratozoospermia.ti,ab |
| 36 | Asthenoteratozoospermias.ti,ab |
| 37 | Or 30 to 36 |
| 38 | 6 and 17 and 29 and 37 |
Figure 1Flow chart of the trial selection process. RCT = randomized controlled trial.
Characteristics of the included studies on acupuncture for oligospermia and asthenozoospermia.
| Study (yr) | Sample (n): age | Duration of disease | Experimental group | Control group | Treatment (T)Follow-up (F) | Outcome measurements | AdverseEvents (n) |
| Gurfinkel et al (2003)[ | E (8): mean 33.4 yrC (10): mean 31.6 yr | E: median 7.6 yrC: median 6.1 yr | Manual acupuncture and moxa | Placebo acupuncture | T: 10 wkF: NR | Percentage of normal-form sperm | NR |
| Dieterle et al (2010)[ | E (24): NRC (28):NR | NR | Manual acupuncture | Placebo acupuncture | T: 6 wkF: 2 mo | 1.Sperm motility2.Sperm concentration3.Semen volume | No adverse events |
| Zhang et al (2016)[ | E (30): 31.68 ± 1.85 yrC (30):32.15 ± 1.45 yr | E: 2.45 ± 1.25 yrC: 2.35 ± 1.46 yr | Fire needle and manual acupuncture | Clomiphene | T: 12 wkF:NR | Sperm motility | NR |
| Sun et al (2016)[ | E (42): 32 ± 3 yrC (40): 31 ± 3 yr | E: 6.4 ± 0.5 yrC: 6.3 ± 0.3 yr | Manual acupuncture | Placebo acupuncture | T: 12 wkF:NR | 1.Sperm motility2.Sperm concentration | NR |
| Wang et al (2016)[ | E (37): 26.38 ± 3.54 yrC (38): 26.16 ± 3.16 yr | E: 35.62 ± 5.61 moC: 34.84 ± 4.65 mo | Manual acupuncture | Vitamin E and vitamin C | T: 3 moF: NR | 1.Sperm motility2.Sperm concentration | E: 1 case with fainting during acupunctureC: 0 |
| Li et al (2017)[ | E1 (40): 30.43 ± 3.27 yrE2 (40): 32.14 ± 3.37 yrC (40): 29.95 ± 3.32 yr | E1: 4.66 ± 1.97 yrE2: 4.75 ± 2.35 yrC: 5.05 ± 2.63 yr | E1 Tamoxifen+TEASE2 TEAS | Tamoxifen | T: 8 wkF: NR | 1. Sperm motility2.Sperm concentration | NR |
| Liu et al (2017)[ | E1 (40): NRE2 (40): NRC (40): NR | NR | E1 | T: 3 morF:NR | 1.Sperm motility2.Sperm concentration3.Semen volume | NR |
Selected acupoints of each study.
| Study (year) | Acupoints |
| Gurfinkel et al(2003)[ | Qichong (ST 30), Taixi (KI 3), Zusanli (ST 36), Hegu (LI 4), Sanyinjiao (SP 6), Gongsun (SP 4), Taichong (LR 3), Neiguan (PE 6) |
| Dieterle et al(2010)[ | Zusanli (ST 36), Sanyinjiao (SP 6), Taixi (KI 3), Taichong (LR 3), Shenshu (BL 23), Ciliao (BL 32), Guilai (ST 29), Xuehai (SP 10), Guanyuan (RN 4), Baihui (DU 20) |
| Zhang et al (2016)[ | Shenshu (BL 23), Zusanli (ST 36), Taixi (KI 3), Taichong (LR 3), Baihui (DU 20) |
| Sun et al (2016)[ | Guanyan (RN 4), Qihai (RN 6), Baihui (DU 20), Zusanli (ST 36), Yinlinquan (SP 9), Sanyinjiao (SP 6) |
| Wang et al (2016)[ | Guanyan (RN 4), Qihai (RN 6), Sanyinjiao (SP 6), Zusanli (ST 36), Fenglong (ST 40), Shenshu (BL 23), Mingmen (DU 4), Taixi (KI 3), Ciliao (BL 32) |
| Li et al (2017)[ | Guanyan (RN 4), Sanyinjiao (SP 6), Zusanli (ST 36), Shenshu (BL 23), Yongquan(KI 1) |
| Liu et al (2017)[ | Dazhui (DU 14), Taodao (DU 13), Shenzhu (DU 12), Shendao (DU 11), Lingtai (DU 10), Zhiyang (DU 9), Jinsuo (DU 8), Zhongshu (DU 7), Jizhong(DU 6), Xuanshu (DU 5), Mingmen (DU 4), Yaoyangguan (DU 3) |
Figure 2Summary of the risk of bias of the included trials.
Figure 3Meta-analysis of the sperm motility of the acupuncture versus placebo acupuncture. CI = confidence interval, SD = standard deviation.
Figure 4Meta-analysis of the sperm concentration of the acupuncture versus placebo acupuncture. CI = confidence interval, SD = standard deviation.
Figure 5Meta-analysis of the sperm motility of the acupuncture versus drugs. CI = confidence interval, SD = standard deviation.
Figure 6Meta-analysis of the sperm concentration of the acupuncture versus drugs. CI = confidence interval, SD = standard deviation.
Figure 7Meta-analysis of the sperm motility of the acupuncture plus drugs versus the same drugs. CI = confidence interval, SD = standard deviation.
Figure 8Meta-analysis of the sperm concentration of the acupuncture plus drugs versus the same drugs. CI = confidence interval, SD = standard deviation.